Attention DisturbancesNCT05296252
Attention and Achievement: A Mind Wandering Investigation
A study testing mind-wandering intervention and mind-wandering comparison in people with Attention Disturbances, run by University of Houston at 1 site in United States.
Trial summary
This study assesses the impact of mind-wandering on reading and math. Read more about this study
- Who is it for?
- Ages 11 to 15 yearsHealthy volunteers can take part
- Conditions the study is for
- Attention Disturbances
- What is being tested?
- mind-wandering intervention and mind-wandering comparison
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 53 participants
- Where
- 1 siteUnited States
- Study dates
- 11 May 2022to 15 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 11 to 15 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- enrollment in schools where we have permission to conduct the study
Who cannot join
- students known to be enrolled in separate curricula (e.g., life-skills classes)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Attention and Achievement (A Subproject Affiliated With the Texas Center for Learning Disabilities or TCLD)
This study assesses the impact of mind-wandering on reading and math.
Read the detailed description
This study assesses the impact of mind-wandering on reading and math. Specifically 120 middle school student participants will receive descriptive measures (of achievement, attention and related factors including mind-wandering), and will receive a brief (~30 min) lesson in reading and math (order counterbalanced). Participants will receive a brief pre-test, the lesson, and then a post-test on the reading and math outcomes. 75% of the participants will receive a brief manipulation that sets up the influence of mind-wandering, as well as redirects when probe-caught mind-wandering occurs. The remaining participants will receive only redirects, and only randomly. Among participants to receive the mind-wandering manipulation, an equal number will receive this only for reading, only for math, and for both reading and math.
- Conditions
- Attention Disturbances
- Being tested
- mind-wandering intervention, mind-wandering comparison
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mind-wandering interventionBehavioural
Participants in this condition receive a brief introduction to the potential impact of mind-wandering (before learning, proactive), and are redirected to lesson if "probe-caught" mind-wandering are endorsed (during learning, reactive)
mind-wandering comparisonBehavioural
Participants in this condition receive no introduction, and only redirection, and the redirection is random, not in reaction to mind-wandering
| Study group | Role | What they receive |
|---|---|---|
| Mind Wandering Intervention | Experimental | 75% of participants will receive proactive and reactive mind-wandering information and redirection. Receives: Behavioral: mind-wandering intervention |
| Mind Wandering Comparison | Active comparator | 25% of participants will receive only mind-wandering redirection, but only at random times. Receives: Behavioral: mind-wandering comparison |
What is being measured
The primary outcome is the main question the study is designed to answer.
Investigator Developed Items Derived From Reading Content Being Taught
Participants will answer multiple choice questions regarding the reading material being taught, and the key index will the raw score number correct. The investigators call the scale "Sleep and Dreams" (after the content the participant is reading about), and the possible score range will be 0 (min) to 24 (max), with higher scores meaning better comprehension of the material.
Measured: administered one time immediately following the single reading learning session on day 1
Investigator Developed Items Derived From Math Content Being Taught
Participants will answer multiple choice questions regarding the math material being taught, and the key index will the raw score number correct. The investigators call the scale "Circles" (after the content being taught), and the possible score range will be 0 (min) to 24 (max), with higher scores meaning better comprehension of the material.
Measured: adminstered one time immediately following the single math learning session on day 1
Secondary outcomes (1)
Investigator Developed Probe-Caught Mind-Wandering
During the learning (of the reading and math content), participants are prompted on several occasions as to whether their mind was wandering during the lesson. This is a single item multiple/choice scale (called Probe-Caught Mind Wandering), with the range being 0 (min) to 12 (max), with lower scores indicating the better outcome (less mind wandering)
Measured: On 12 occasions interspersed during each of the math and reading learning sessions, on day 1 only.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2022
- Study start11 May 2022
- Primary completion15 Jun 2022
- Study completion15 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Attention DisturbancesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- The factors are study condition order (reading, math), proactive and reactive mind-wandering manipulation (yes, no), and lesson target (reading, math, both, neither)
- Masking
- None (open label)
- Enrolment
- 53 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Houston
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Paul T. Cirino, PhD, Principal investigator, University of Houston
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05296252
- Sponsor's protocol ID
- 00000568
- Status last verified
- May 2022
- First submitted
- 25 Jan 2022
- Last updated
- 19 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: If another researcher with an approved Institutional Review Board (IRB) protocol wishes to utilize the data for purposes that are non-overlapping with the investigators, they may reach out to the Study PI, who can share de-identified individual data.
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Attention and Achievement (A Subproject Affiliated With the Texas Center for Learning Disabilities or TCLD)
- ClinicalTrials.gov ID
- NCT05296252
- Acronym / sponsor ID
- 00000568
- Conditions
- Attention Disturbances
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 53 participants (actual)
- Lead sponsor
- University of HoustonUniversity, hospital or other
- Study start
- 11 May 2022 (actual)
- Primary completion
- 15 Jun 2022 (actual)
- Study completion
- 15 Jun 2022 (actual)
- First posted
- 25 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study assesses the impact of mind-wandering on reading and math.
Detailed description
This study assesses the impact of mind-wandering on reading and math. Specifically 120 middle school student participants will receive descriptive measures (of achievement, attention and related factors including mind-wandering), and will receive a brief (~30 min) lesson in reading and math (order counterbalanced). Participants will receive a brief pre-test, the lesson, and then a post-test on the reading and math outcomes. 75% of the participants will receive a brief manipulation that sets up the influence of mind-wandering, as well as redirects when probe-caught mind-wandering occurs. The remaining participants will receive only redirects, and only randomly. Among participants to receive the mind-wandering manipulation, an equal number will receive this only for reading, only for math, and for both reading and math.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The factors are study condition order (reading, math), proactive and reactive mind-wandering manipulation (yes, no), and lesson target (reading, math, both, neither)
| Arm | Type | Receives |
|---|---|---|
| Mind Wandering Intervention | Experimental | Behavioral: mind-wandering intervention75% of participants will receive proactive and reactive mind-wandering information and redirection. |
| Mind Wandering Comparison | Active comparator | Behavioral: mind-wandering comparison25% of participants will receive only mind-wandering redirection, but only at random times. |
Who may qualify
- Ages
- 11 to 15 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- enrollment in schools where we have permission to conduct the study
Key exclusion criteria (1 listed)
- students known to be enrolled in separate curricula (e.g., life-skills classes)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mind-wandering interventionParticipants in this condition receive a brief introduction to the potential impact of mind-wandering (before learning, proactive), and are redirected to lesson if "probe-caught" mind-wandering are endorsed (during learning, reactive) | Behavioural | Mind Wandering Intervention |
| mind-wandering comparisonParticipants in this condition receive no introduction, and only redirection, and the redirection is random, not in reaction to mind-wandering | Behavioural | Mind Wandering Comparison |
Primary outcome
Investigator Developed Items Derived From Reading Content Being Taught
Time frame: administered one time immediately following the single reading learning session on day 1
Participants will answer multiple choice questions regarding the reading material being taught, and the key index will the raw score number correct. The investigators call the scale "Sleep and Dreams" (after the content the participant is reading about), and the possible score range will be 0 (min) to 24 (max), with higher scores meaning better comprehension of the material.
Investigator Developed Items Derived From Math Content Being Taught
Time frame: adminstered one time immediately following the single math learning session on day 1
Participants will answer multiple choice questions regarding the math material being taught, and the key index will the raw score number correct. The investigators call the scale "Circles" (after the content being taught), and the possible score range will be 0 (min) to 24 (max), with higher scores meaning better comprehension of the material.
1 secondary outcome
Investigator Developed Probe-Caught Mind-Wandering
Time frame: On 12 occasions interspersed during each of the math and reading learning sessions, on day 1 only.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2023.
- Individual participant dataSharing planned: Yes. If another researcher with an approved Institutional Review Board (IRB) protocol wishes to utilize the data for purposes that are non-overlapping with the investigators, they may reach out to the Study PI, who can share de-identified individual data.
Related trials for Attention Disturbances
RecruitingObservational study
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension
Recruiting
Retail-Grade Weighted Blanket Effectiveness on ADHD-related Sleep Disturbances (BEAD)
ADHD - Attention Deficit Disorder With Hyperactivity
Recruiting
Low-intensity TUS for Sleep Disturbances in Patients With Chronic Tinnitus
Tinnitus, Sleep Disturbances
Recruiting
Intervention With Weighted Blankets for Children With ADHD and Sleep Problems: Implementation and Effectiveness
ADHD, Sleep Disturbances
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Paul T. Cirino, PhD principal investigator
University of Houston
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing mind-wandering intervention and mind-wandering comparison in people with Attention Disturbances, run by University of Houston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Investigator Developed Items Derived From Reading Content Being Taught (time frame: administered one time immediately following the single reading learning session on day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2023.